0HC7 Stock Overview
Develops, manufactures, and markets engineered specialty chemicals worldwide. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 2/6 |
Albemarle Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$109.14 |
52 Week High | US$153.46 |
52 Week Low | US$71.91 |
Beta | 1.55 |
11 Month Change | 13.29% |
3 Month Change | 21.17% |
1 Year Change | -13.44% |
33 Year Change | -60.10% |
5 Year Change | 66.96% |
Change since IPO | -4.61% |
Recent News & Updates
Recent updates
Shareholder Returns
0HC7 | GB Chemicals | GB Market | |
---|---|---|---|
7D | 7.1% | -0.8% | 0.7% |
1Y | -13.4% | -18.0% | 6.1% |
Return vs Industry: 0HC7 exceeded the UK Chemicals industry which returned -18% over the past year.
Return vs Market: 0HC7 underperformed the UK Market which returned 6.1% over the past year.
Price Volatility
0HC7 volatility | |
---|---|
0HC7 Average Weekly Movement | 8.9% |
Chemicals Industry Average Movement | 5.7% |
Market Average Movement | 4.7% |
10% most volatile stocks in GB Market | 10.4% |
10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0HC7's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: 0HC7's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1887 | 9,000 | Jerry Masters | www.albemarle.com |
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.
Albemarle Corporation Fundamentals Summary
0HC7 fundamental statistics | |
---|---|
Market cap | US$12.88b |
Earnings (TTM) | -US$1.97b |
Revenue (TTM) | US$6.50b |
2.0x
P/S Ratio-6.5x
P/E RatioIs 0HC7 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
0HC7 income statement (TTM) | |
---|---|
Revenue | US$6.50b |
Cost of Revenue | US$7.27b |
Gross Profit | -US$768.73m |
Other Expenses | US$1.20b |
Earnings | -US$1.97b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -16.74 |
Gross Margin | -11.82% |
Net Profit Margin | -30.26% |
Debt/Equity Ratio | 33.0% |
How did 0HC7 perform over the long term?
See historical performance and comparisonDividends
1.5%
Current Dividend Yield-10%
Payout RatioDoes 0HC7 pay a reliable dividends?
See 0HC7 dividend history and benchmarksAlbemarle dividend dates | |
---|---|
Ex Dividend Date | Dec 13 2024 |
Dividend Pay Date | Jan 02 2025 |
Days until Ex dividend | 21 days |
Days until Dividend pay date | 41 days |
Does 0HC7 pay a reliable dividends?
See 0HC7 dividend history and benchmarks